[
  {
    "pageContent": "{\"position\":1,\"title\":\"Efficacy of statins for primary prevention in people at low ...\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216447/\",\"redirect_link\":\"https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216447/&ved=2ahUKEwiTorWa29yDAxWbv4kEHcW2DW0QFnoECBcQAQ\",\"displayed_link\":\"https://www.ncbi.nlm.nih.gov › articles › PMC3216447\",\"favicon\":\"https://serpapi.com/searches/65a3bd0911c881f6a7dd3144/images/24573ab0ef48738c1074e6d4b673f2ed83ca3e53d7914e2bf498f0e365b10f9e.png\",\"author\":\"by M Tonelli\",\"cited_by\":\"Cited by 213\",\"extracted_cited_by\":213,\"date\":\"2011\",\"snippet\":\"Statins were found to be efficacious in preventing death and cardiovascular morbidity in people at low cardiovascular risk. Reductions in relative risk were ...\",\"snippet_highlighted_words\":[\"Statins\",\"efficacious\",\"preventing\",\"cardiovascular\",\"cardiovascular\"],\"sitelinks\":{\"inline\":[{\"title\":\"Efficacy Of Statins For...\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216447/#:~:text=Efficacy%20of%20statins%20for%20primary%20prevention%20in%20people%20at%20low%20cardiovascular%20risk%3A%20a%20meta%2Danalysis,-Marcello%20Tonelli%2C%20MD%20SM\"},{\"title\":\"Table 1\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216447/#:~:text=Table%201%3A\"},{\"title\":\"Table 3\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216447/#:~:text=Table%203%3A\"}]},\"source\":\"nih.gov\"}",
    "metadata": {
      "source": "SerpAPI",
      "responseType": "organic_results"
    }
  },
  {
    "pageContent": "{\"position\":2,\"title\":\"Rosuvastatin: A Review of the Pharmacology and Clinical ...\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303484/\",\"redirect_link\":\"https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303484/&ved=2ahUKEwiTorWa29yDAxWbv4kEHcW2DW0QFnoECBAQAQ\",\"displayed_link\":\"https://www.ncbi.nlm.nih.gov › articles › PMC3303484\",\"favicon\":\"https://serpapi.com/searches/65a3bd0911c881f6a7dd3144/images/24573ab0ef48738c1074e6d4b673f2edd970340ac8bf3e9703dbc01e5d4b7e9a.png\",\"author\":\"by A Luvai\",\"cited_by\":\"Cited by 189\",\"extracted_cited_by\":189,\"date\":\"2012\",\"snippet\":\"The 4S study was the first study conclusively linking a statin with improved outcomes in patients with coronary heart disease. It established ...\",\"snippet_highlighted_words\":[\"improved outcomes\"],\"source\":\"nih.gov\"}",
    "metadata": {
      "source": "SerpAPI",
      "responseType": "organic_results"
    }
  },
  {
    "pageContent": "{\"position\":3,\"title\":\"Efficacy and safety of the intensive dose of rosuvastatin 40 ...\",\"link\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143813/\",\"redirect_link\":\"https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143813/&ved=2ahUKEwiTorWa29yDAxWbv4kEHcW2DW0QFnoECBEQAQ\",\"displayed_link\":\"https://www.ncbi.nlm.nih.gov › articles › PMC5143813\",\"favicon\":\"https://serpapi.com/searches/65a3bd0911c881f6a7dd3144/images/24573ab0ef48738c1074e6d4b673f2edbe2f81983f9029e138e7234f888abbd6.png\",\"author\":\"by CP Shah\",\"cited_by\":\"Cited by 15\",\"extracted_cited_by\":15,\"date\":\"2016\",\"snippet\":\"The study showed that rosuvastatin 20 mg is as effective as atorvastatin 80 mg in intensive statin treatment. There is dearth of data on effect ...\",\"snippet_highlighted_words\":[\"rosuvastatin 20 mg is as effective as atorvastatin 80 mg\"],\"source\":\"nih.gov\"}",
    "metadata": {
      "source": "SerpAPI",
      "responseType": "organic_results"
    }
  }
]